A. Mongeot

Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2009, Cellular and Molecular Life Sciences.

Synthesis of potent water-soluble tissue transglutaminase inhibitors.

Richard A. Jones, R. Collighan, D. Rathbone, 2008, Bioorganic & medicinal chemistry letters.

Toward versatile methods leading to highly functionalized imidazo[1,2-a]pyridines

J. Bourguignon, M. Schmitt, T. Aquino, 2012 .

Microwave-assisted cyclic amidine synthesis using TiCl4.

F. Bihel, J. Bourguignon, Malik Hellal, 2006, Organic & biomolecular chemistry.

Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2011, Clinical and experimental immunology.

Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2010, Scandinavian journal of gastroenterology.

Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.

R. Collighan, D. Rathbone, M. Griffin, 2013, European journal of medicinal chemistry.

Prefrontal cortex and reversion of atropine-induced disruption of the degraded contingency effect by antipsychotic agents and N-desmethylclozapine in rats.

J. Bourguignon, S. Carnicella, P. Oberling, 2010, The international journal of neuropsychopharmacology.